Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome

@article{Grassi2005NeuroadrenergicAR,
  title={Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome},
  author={G. Grassi and R. Dell'oro and F. Quarti-Trevano and F. Scopelliti and G. Seravalle and F. Paleari and P. Gamba and G. Mancia},
  journal={Diabetologia},
  year={2005},
  volume={48},
  pages={1359-1365}
}
Aims/hypothesisPrevious studies have shown that alterations in vascular, metabolic, inflammatory and haemocoagulative functions characterise the metabolic syndrome. Whether this is also the case for sympathetic function is not clear. We therefore aimed to clarify this issue and to determine whether metabolic or reflex mechanisms might be responsible for the possible adrenergic dysfunction.MethodsIn 43 healthy control subjects (age 48.2±1.0 years, mean±SEM) and in 48 untreated age-matched… Expand
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea
TLDR
The sympathetic activation of metabolic syndrome occurs independently on OSA, however, OSA markedly potentiates this neuroadrenergic abnormality via a hypoxic-dependent chemoreflex activation. Expand
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome
TLDR
The data show that in the metabolic syndrome not only peripheral but also cardiac sympathetic drive is markedly potentiated and HR can be regarded as a marker of adrenergic overdrive characterizing this clinical condition. Expand
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
TLDR
Evidence is presented that non-pharmacologic life-style interventions as well as drug treatment procedures used in the therapeutic approach to the metabolic syndrome should be aimed at exerting not only favourable haemodynamic and metabolic effects but also pronounced sympathoinhibition. Expand
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
TLDR
Indirect and direct markers of sympathetic drive have confirmed the hypothesis that an adrenergic overdrive may be implicated in the development and/or progression of the metabolic syndrome, and suggested that sympathetic inhibition should be included among the goals of both pharmacological and non-pharmacological interventions employed in the treatment of the metabolism syndrome. Expand
Neuroadrenergic Dysfunction Along the Diabetes Continuum
TLDR
It is demonstrated that progression to T2D is associated with increased central sympathetic drive, blunted sympathetic responsiveness, and altered norepinephrine disposition. Expand
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease
TLDR
In addition to significant reductions in plasma leptin levels, acromegalic patients had markedly decreased MSNA compared with the healthy controls, the first evidence that the sympathetic inhibition characterizing the early phase of acromegaly is not generalized to the entire cardiovascular system. Expand
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies.
TLDR
Evidence is provided that metabolic syndrome is characterized by a marked increase in MSNA, and among the variables included in metabolic syndrome definition and related to the sympathetic overdrive blood pressure appears to be the most important one, at variance from what described in obesity in which metabolic and anthropometric factors play a major role. Expand
Mechanical and metabolic reflex activation of the sympathetic nervous system in younger adults with metabolic syndrome
TLDR
Sympathetic and pressor responses to mechanoreflex and metaboreflex activation are not augmented in younger adults with metabolic syndrome, and responses were not different between groups. Expand
The sympathetic nervous system and the metabolic syndrome.
TLDR
The behaviour of the sympathetic nervous system in the metabolic syndrome as well as the mechanisms potentially responsible for this neurogenic abnormality are examined. Expand
Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects.
TLDR
This is the first demonstration that arterial norepinephrine and NEFA, that reflect both SNS activity and IR, associate significantly with circulating complex lipids independently of IR, suggesting a role for such lipids in neural mechanisms operating in MetS. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study
TLDR
This case-control study provides the first evidence that chronic stress may be a cause of MS and reversibility and power of psychosocial and behavioral factors to explain the neuroendocrine adaptations that accompany MS. Expand
Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension
TLDR
It is suggested that MS is a state of sympathetic nerve hyperactivity and that the additional presence of hypertension further intensifies this hyperactivity. Expand
Sympathetic activation in obese normotensive subjects.
Human obesity is characterized by profound alterations in the hemodynamic and metabolic states. Whether these alterations involve sympathetic drive is controversial. In 10 young obese subjects (bodyExpand
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.
TLDR
Reduction in body weight induced by a hypocaloric diet with normal sodium content exerts a marked reduction in sympathetic activity owing to central sympathoinhibition, which can be due to the consequences of an increased insulin sensitivity but also to a restoration of the baroreflex control of the cardiovascular system with weight loss. Expand
Metabolic syndrome and target organ damage in untreated essential hypertensives
TLDR
The results from a representative sample of untreated middle-aged hypertensives show that: (i) the metabolic syndrome is highly prevalent in this setting and (ii) despite similar ambulatory blood pressure values, patients with metabolic syndrome have a more pronounced cardiac and extracardiac involvement than those without it. Expand
Metabolic manifestations of low-dose diuretics.
  • J. Neutel
  • Medicine
  • The American journal of medicine
  • 1996
TLDR
Recent data have demonstrated that when used at low doses, diuretics lack significant metabolic side effects while bringing about significant reductions in blood pressure, and hydrochlorothiazide is a useful drug in the treatment of hypertension, both as monotherapy and in combination therapy. Expand
Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients
TLDR
The data show that the sympathetic activation characterizing CHF is markedly potentiated when O and H alone or combined together are associated with a low cardiac output state and that this may depend on an arterial baroreflex impairment. Expand
How to assess sympathetic activity in humans.
TLDR
The present paper will review in detail the haemodynamic, pharmacological, biochemical, neurophysiological, neurochemical and neural imaging techniques by which sympathetic activity is assessed in humans, highlighting the main advantages and limitations of each of them. Expand
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.
TLDR
It is hypothesized that the metabolic abnormalities linked to the hypertension by a pathophysiologic process that involves the sympathoadrenal system and exerts influence on blood pressure and complications in many patients. Expand
Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.
TLDR
OSA is independently associated with an increase in the cardiovascular risk factors that comprise the metabolic syndrome and its overall prevalence, which may help explain the increased cardiovascular morbidity and mortality associated with this condition. Expand
...
1
2
3
4
5
...